Literature DB >> 10319388

Indolent nonfollicular lymphomas: characteristics, treatment, and outcome.

B Coiffier1, C Thieblemont, P Felman, G Salles, F Berger.   

Abstract

Indolent lymphomas are defined by their low aggressiveness at diagnosis compared with large-cell or T-cell lymphomas: small lymph nodes or blood involvement usually existing for months or years, no B symptoms, and good performance status. However, except in mucosa-associated lymphoid tissue (MALT) lymphoma, the disease is usually disseminated and this indolent presentation does not preclude a good outcome. Indolent lymphomas consist of follicular lymphoma, small lymphocytic lymphoma (SLL), lymphoplasmacytic lymphoma (LPL), marginal-zone lymphoma (MZL), and mantle-cell lymphoma (MCL) as defined in the World Health Organization (WHO) classification. A review of morphologic characteristics, clinical presentation, prognostic factors, and outcome is presented here for each of these entities. Despite the absence of good prospective or retrospective studies in the literature, some orientations for the treatment of these patients are given, as well as some ideas for future studies.

Entities:  

Mesh:

Year:  1999        PMID: 10319388

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  4 in total

1.  Induction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice.

Authors:  S Rosic-Kablar; K Chan; M D Reis; I D Dubé; M R Hough
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 2.  Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders.

Authors:  G A Pangalis; M N Dimopoulou; M K Angelopoulou; C Tsekouras; T P Vassilakopoulos; G Vaiopoulos; M P Siakantaris
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

3.  Rituximab and bortezomib (RB): a new effective regimen for refractory or relapsed indolent lymphomas.

Authors:  Hou Yun; Hui Lai Zhang; Hua-Qing Wang
Journal:  Med Oncol       Date:  2014-12-16       Impact factor: 3.064

4.  Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia.

Authors:  Kamel Laribi; Habib Ghnaya; Pierre-Jean Mention; Hoel Rousset; Alix Baugier de Materre; Fabienne Pineau-Vincent; Catherine Truong; Delphine Bolle
Journal:  Clin Case Rep       Date:  2015-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.